Initiation of Enrollment in Linaclotide (LINZESS) Phase III IBS-C Clinical Trial

LINZESS for IBS-C

Ironwood Pharmaceuticals, Inc. (IRWD) announced today that it has earned a $15 million development milestone payment from Astellas Pharma Inc., its partner for linaclotide (LINZESS) in Japan. This milestone was triggered by Astellas’s enrollment of the first patient in a randomized, double-blind, placebo-controlled Phase III clinical trial of linaclotide in adult patients with irritable bowel syndrome … Read moreInitiation of Enrollment in Linaclotide (LINZESS) Phase III IBS-C Clinical Trial

Stanford University – Acupuncture Benefits For Children

Stanford University - Acupuncture Eases Pain For Children

A Stanford University study finds acupuncture safe and cost-effective for relieving pain in children. Dr. Golianu, MD (Department of Anesthesiology, Stanford University), et. al., note research confirming that acupuncture is “useful in chronic pain conditions” adding that it may be clinically valuable in an integrative medical setting. The research documents acupuncture’s ability to stimulate natural pain … Read moreStanford University – Acupuncture Benefits For Children

New Guideline For Treatment Of Irritable Bowel Syndrome

AGA Releases Irritable Bowel Syndrome Drug Treatment Guideline (1)

  The American Gastroenterological Association (AGA) has released a new guideline that includes recommendations on drugs for the treatment of irritable bowel syndrome (IBS). The document, which was recently published in the Gastroenterology journal, aims to help patients as well as physicians decide the best treatments for the disease’s symptoms, and the association believes that it provides an evidence-based tool to … Read moreNew Guideline For Treatment Of Irritable Bowel Syndrome

Irritable Bowel Syndrome Epidemiology Forecast to 2023

Irritable Bowel Syndrome Epidemiology Forecast to 2023

IBS is one of the most common gastrointestinal disorders; moreover, it has a significant negative impact on a patient’s quality of life and social functioning. That said, IBS is not known to be associated with the development of serious disease or with excess mortality. Several factors, including psychological disorders, stress, environmental factors, infection, and inflammation … Read moreIrritable Bowel Syndrome Epidemiology Forecast to 2023

Understanding Gender Differences in IBS – New Findings

Understanding Gender Differences in IBS - New Findings

One of the few studies to examine gender differences among patients with irritable bowel syndrome (IBS) has found that males with the condition experience more interpersonal difficulties than do females with the condition. The findings challenge what had been predicted by the UB investigator and his colleagues. The study, “Understanding gender differences in IBS: the … Read moreUnderstanding Gender Differences in IBS – New Findings